Skip to main
  1. Stocks
  2. Agilon Health
  3. Forecast
AGL

Agilon Health (AGL) Stock Forecast & Price Target

Agilon Health (AGL) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 15%
Hold 46%
Sell 8%
Strong Sell 0%

Bulls say

Agilon Health is viewed positively because repeated quarterly beats and guidance raises point to a business that is improving faster than expected, driven by favorable risk adjustment, better payer contracting, stronger ACO performance, and tighter control of medical costs. Revenue of $1.49 billion to $1.52 billion was up 6% to 7% year over year, while medical margins of 11.5% and $197 million materially exceeded guidance, and FY26 AEBITDA guidance rose from $30 million or $85 million to as high as $145 million-$155 million. The outlook is further supported by expansion in high-risk patient management programs, lower estimated cost trends at 5.8%, and solid financial flexibility with $257 million in cash and only $32 million of debt, positioning FY27 for further margin expansion and cash positivity.

Bears say

Agilon Health is exposed to a fragile operating model because its growth depends on identifying and developing successful new markets while also relying heavily on payors for membership attribution, reporting accuracy, claims payments, and risk adjustment factors that determine reimbursement. This creates meaningful execution risk, as any disruption in payor data quality or reimbursement mechanics could quickly pressure margins and make it harder to achieve and maintain profitability. In addition, competition and ongoing industry consolidation may intensify pricing pressure and limit the company’s ability to scale efficiently, reinforcing a negative fundamental outlook.

Agilon Health (AGL) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 15% recommend Buy, 46% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Agilon Health and is not a guaranteed prediction by Public.com or investment advice.

Agilon Health (AGL) Analyst Forecast & Price Prediction

Get the latest Agilon Health (AGL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Agilon Health (AGL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Agilon Health (AGL) Forecast

Analysts have given Agilon Health (AGL) a Buy based on their latest research and market trends.

According to 13 analysts, Agilon Health (AGL) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Agilon Health (AGL)


Agilon Health (AGL) Analyst Forecast & Price Prediction

Get the latest Agilon Health (AGL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Agilon Health (AGL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover AGL stock data and trends